Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar 22:8:17.
doi: 10.1186/1741-7015-8-17.

Current sample size conventions: flaws, harms, and alternatives

Affiliations
Review

Current sample size conventions: flaws, harms, and alternatives

Peter Bacchetti. BMC Med. .

Abstract

Background: The belief remains widespread that medical research studies must have statistical power of at least 80% in order to be scientifically sound, and peer reviewers often question whether power is high enough.

Discussion: This requirement and the methods for meeting it have severe flaws. Notably, the true nature of how sample size influences a study's projected scientific or practical value precludes any meaningful blanket designation of <80% power as "inadequate". In addition, standard calculations are inherently unreliable, and focusing only on power neglects a completed study's most important results: estimates and confidence intervals. Current conventions harm the research process in many ways: promoting misinterpretation of completed studies, eroding scientific integrity, giving reviewers arbitrary power, inhibiting innovation, perverting ethical standards, wasting effort, and wasting money. Medical research would benefit from alternative approaches, including established value of information methods, simple choices based on cost or feasibility that have recently been justified, sensitivity analyses that examine a meaningful array of possible findings, and following previous analogous studies. To promote more rational approaches, research training should cover the issues presented here, peer reviewers should be extremely careful before raising issues of "inadequate" sample size, and reports of completed studies should not discuss power.

Summary: Common conventions and expectations concerning sample size are deeply flawed, cause serious harm to the research process, and should be replaced by more rational alternatives.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Qualitative depiction of how sample size influences a study's projected scientific and/or practical value. A threshold shaped relationship (dashed line) would create a meaningful distinction between adequate and inadequate sample sizes, but such a relation does not exist. The reality (solid line) is qualitatively different, exhibiting diminishing marginal returns. Under the threshold myth, cutting a sample size in half could easily change a valuable study into an inadequate one, but in reality such a cut will always preserve more than half of the projected value.

Similar articles

  • The future of Cochrane Neonatal.
    Soll RF, Ovelman C, McGuire W. Soll RF, et al. Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
  • Simple, defensible sample sizes based on cost efficiency.
    Bacchetti P, McCulloch CE, Segal MR. Bacchetti P, et al. Biometrics. 2008 Jun;64(2):577-85; discussion 586-94. doi: 10.1111/j.1541-0420.2008.01004_1.x. Biometrics. 2008. PMID: 18482055 Free PMC article.
  • Statistics for Sleep and Biological Rhythms Research.
    Bianchi MT, Phillips AJ, Wang W, Klerman EB. Bianchi MT, et al. J Biol Rhythms. 2017 Feb;32(1):7-17. doi: 10.1177/0748730416670050. Epub 2016 Oct 25. J Biol Rhythms. 2017. PMID: 27836938 Free PMC article.
  • The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, Charles D, Chiles TC, Donohue MJ, Enck J, Fenichel P, Fleming LE, Ferrier-Pages C, Fordham R, Gozt A, Griffin C, Hahn ME, Haryanto B, Hixson R, Ianelli H, James BD, Kumar P, Laborde A, Law KL, Martin K, Mu J, Mulders Y, Mustapha A, Niu J, Pahl S, Park Y, Pedrotti ML, Pitt JA, Ruchirawat M, Seewoo BJ, Spring M, Stegeman JJ, Suk W, Symeonides C, Takada H, Thompson RC, Vicini A, Wang Z, Whitman E, Wirth D, Wolff M, Yousuf AK, Dunlop S. Landrigan PJ, et al. Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023. Ann Glob Health. 2023. PMID: 36969097 Free PMC article. Review.
  • Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.
    Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G. Brookes ST, et al. Health Technol Assess. 2001;5(33):1-56. doi: 10.3310/hta5330. Health Technol Assess. 2001. PMID: 11701102 Review.

Cited by

References

    1. Halpern SD, Karlawish JHT, Berlin JA. The continuing unethical conduct of underpowered clinical trials. JAMA-Journal of the American Medical Association. 2002;288:358–362. doi: 10.1001/jama.288.3.358. - DOI - PubMed
    1. Edwards SJL, Lilford RJ, Braunholtz D, Jackson J. Why "underpowered" trials are not necessarily unethical. Lancet. 1997;350:804–807. doi: 10.1016/S0140-6736(97)02290-3. - DOI - PubMed
    1. Guyatt GH, Mills EJ, Elbourne D. In the era of systematic reviews, does the size of an individual trial still matter? PLoS Medicine. 2008;5:3–5. doi: 10.1371/journal.pmed.0050004. - DOI - PMC - PubMed
    1. Vail A. Experiences of a biostatistician on a UK research ethics committee. Statistics in Medicine. 1998;17:2811–2814. doi: 10.1002/(SICI)1097-0258(19981230)17:24<2811::AID-SIM22>3.0.CO;2-1. - DOI - PubMed
    1. Bacchetti P, McCulloch CE, Segal MR. Simple, defensible sample sizes based on cost efficiency. Biometrics. 2008;64:577–585. doi: 10.1111/j.1541-0420.2008.01004_1.x. - DOI - PMC - PubMed

Publication types